-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Overweight on Upexi, Lowers Price Target to $2

Benzinga·02/11/2026 13:47:24
Listen to the news
Cantor Fitzgerald analyst Brett Knoblauch maintains Upexi (NASDAQ:UPXI) with a Overweight and lowers the price target from $6 to $2.